SLC5A2 and type 2 diabetes mellitus: Among patients with type 2 diabetes and CKD, insulin, metformin, and sodium-glucose cotransporter 2 inhibitors were the 3 most commonly prescribed hypoglycemic medications, with utilization rates exceeding 40% (Table S3 in Multimedia Appendix 1).